Clinical Trial Update: Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating irinotecan with or without panitumumab or cyclosporine in advanced/metastatic colorectal cancer refractory to fluorouracil. Study compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Irinotecan (Irinotecan)
• Panitumumab (panitumumab)

Snippet

Sponsor: University of Leeds | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED